Literature DB >> 27882227

G2691A and C2491T mutations of factor V gene and pre-disposition to myocardial infarction in Morocco.

Wiam Hmimech1, Brehima Diakite1, Hind Hassani Idrissi1, Khalil Hamzi1, Farah Korchi2, Dalila Baghdadi2, Rachida Habbal2, Sellama Nadifi1.   

Abstract

Coagulation factor Leiden mutation has been described as a common genetic risk factor for venous thrombosis; however, this mutation was reported to be practically absent in an African population. Recently, a novel non-sense mutation in the gene encoding factor V has been associated with the risk of occurrence of cardio-cerebrovascular diseases such as stroke and venous thrombosis. The aim of the present study was to investigate whether the factor V Leiden (FVL) and C2491T non-sense mutations are associated with the risk of developing myocardial infarction. Genotyping of FVL and C2491T FV was performed using the polymerase chain reaction restriction fragment length polymorphism method on a sample of 100 patients with myocardial infarction as well as 211 controls. In the study population, the frequency of the FVL mutation was practically zero. However, with regard to the C2491T mutation, the TT genotype was associated with an increased risk of myocardial infarction [odds ratio (OR)=3.16, 95% confidence interval (CI): 1.29-7.71, P=0.03]. A significant association between the C2491T FV mutation and the risk of myocardial infarction was identified using recessive (OR=2.74, 95% CI: 1.14-6.58, P=0.04), dominant (OR=1.85, 95% CI: 1.13-3.04, P=0.02) and additive (OR=1.88, 95% CI: 1.25-2.80, P=0.004) models. Furthermore, a positive correlation was found between the presence of the C2491T FV mutation and hypertension (P=0.02), which is associated with myocardial infarction. In conclusion, the results of the present study suggested that the C2491T non-sense mutation of the FV gene may be a risk factor for myocardial infarction in a Moroccan population.

Entities:  

Keywords:  C2491T; factor V Leiden; mutation; myocardial infarction; non-sense

Year:  2016        PMID: 27882227      PMCID: PMC5103682          DOI: 10.3892/br.2016.768

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  23 in total

Review 1.  Molecular risk factors for thrombosis.

Authors:  R M Bertina
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

Review 2.  Risk factors for venous thrombotic disease.

Authors:  F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

3.  Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population.

Authors:  Florence Mathonnet; Sellama Nadifi; Valérie Serazin-Leroy; Mbarka Dakouane; Yves Giudicelli
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249

4.  First study of the C2491t nonsense mutation frequency in moroccan healthy population.

Authors:  K Hamzi; B Diakité; W Hmimech; S Nadifi
Journal:  J Mol Neurosci       Date:  2013-06-15       Impact factor: 3.444

Review 5.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

6.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

7.  Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco.

Authors:  Thierry Paluku They-They; Khalil Hamzi; Mohamed Taha Moutawafik; Hanane Bellayou; Mariame El Messal; Sellama Nadifi
Journal:  Ann Hum Biol       Date:  2010-08-05       Impact factor: 1.533

8.  Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.

Authors:  B Zöller; B Dahlbäck
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

Review 9.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

Authors:  Robert J Kim; Richard C Becker
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  4 in total

1.  Risk of colorectal cancer and clotting factor gene polymorphisms in Moroccan Population.

Authors:  Imane Baghad; Driss Erguibi; Farid Chehab; Sellama Nadifi
Journal:  Int J Adv Res (Indore)       Date:  2017

2.  Mitochondrial Genome Mutations Associated with Myocardial Infarction.

Authors:  Margarita A Sazonova; Anastasia I Ryzhkova; Vasily V Sinyov; Elena V Galitsyna; Alexandra A Melnichenko; Natalya A Demakova; Igor A Sobenin; Tatiana P Shkurat; Alexander N Orekhov
Journal:  Dis Markers       Date:  2018-02-18       Impact factor: 3.434

3.  Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients.

Authors:  Abdulghani Msalati; Abdulla Bashein; Murad Ghrew; Ibtesam Khalil; Khaled Sedaa; Abushawashi Ali; Ahmed Zaid
Journal:  Libyan J Med       Date:  2021-12       Impact factor: 1.657

4.  Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients.

Authors:  Wiam Hmimech; Hind Hassani Idrissi; Brehima Diakite; Farah Korchi; Dalila Baghdadi; Hind Tahri Joutey Hassani Idrissi; Meriem Haboub; Rachida Habbal; Sellama Nadifi
Journal:  BMC Res Notes       Date:  2017-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.